Impact of first SARS-CoV-2 infection variant on serological responses against Omicron: findings from the SIREN study

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Despite the existing hybrid immunity, a sharp increase in SARS-CoV-2 reinfections was observed worldwide following Omicron variant emergence. We investigated whether the first infecting variant indelibly shapes serological responses against Omicron (BA.1 and BA.2) reinfection.

Methods

Participants with a sequence-confirmed Alpha (n=23) or Delta (n=10) first infection before third vaccine dose (V3) that subsequently had a BA.1 or BA.2 reinfection were selected. Sera were tested for anti-SARS-CoV-2 spike (anti-S) and live virus microneutralisation (LV-N) against Ancestral, Alpha, Delta, Omicron BA.1 and BA.2. Antibody responses and waning post-V3 were compared by first infection variant using mixed-effect models, as well as inferred titres 7-days before reinfections. Individual’s neutralisation responses were compared 12 weeks post-V3, among those with Alpha and Delta primary infection.

Results

After V3, those with Delta first infection had higher LV-N Omicron BA.1 titres (fold difference (FD)=2.7, p=0.05) compared to Alpha primary infection. Participants with Delta first infection presented higher LV-N BA.1 (FD=1.89, p=0.004) and LV-N BA.2 (FD 2.06, p=0.001) titres pre-Omicron reinfections. Individuals’ neutralisation responses against Ancestral were higher than any other subsequent variants, regardless of first infection variant.

Discussion

A previous Delta SARS-CoV-2 infection induced a higher serological response against a subsequent Omicron infection when compared to Alpha first infections.

Article activity feed